Synthetic Biologics Sets 1-for-10 Reverse Stock Split_老虎社区_美港股上老虎

Synthetic Biologics Sets 1-for-10 Reverse Stock Split

Dow Jones2022-07-15

By Will Feuer

Synthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American.

The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares.

The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement.

Write to Will Feuer at Will.Feuer@wsj.com

$(END)$ Dow Jones Newswires

July 15, 2022 08:22 ET (12:22 GMT)

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Hbwen
·2022-07-15
这是…
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2251743220?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-07-15 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2251743220","market":"us","top_or_hot":-1,"title":"Synthetic Biologics Sets 1-for-10 Reverse Stock Split","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Will Feuer \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/SYN\">Synthetic Biologics Inc</a>. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n</p>\n<p>\n  The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n</p>\n<p>\n  The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Will Feuer at Will.Feuer@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  July 15, 2022 08:22 ET (12:22 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synthetic Biologics Sets 1-for-10 Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynthetic Biologics Sets 1-for-10 Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-15 20:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American....</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2251743220","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2251743220","pubTimestamp":1657887720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensu","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技"},"translate_title":"合成生物制品集1比10反向库存拆分","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"87164U409":1,"SYN":1},"content_text":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n\n\n  The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n\n\n  The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n\n\n \n\n\n  Write to Will Feuer at Will.Feuer@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  July 15, 2022 08:22 ET (12:22 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":686089265,"gmtCreate":1657890635862,"gmtModify":1704868642117,"author":{"id":"3557441995443761","authorId":"3557441995443761","name":"Hbwen","avatar":"https://static.tigerbbs.com/01d25e0cc29a67de031bdf2427f8c2e6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3557441995443761","authorIdStr":"3557441995443761"},"htmlText":"这是…","listText":"这是…","text":"这是…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/686089265","repostId":2251743220,"repostType":2,"repost":{"id":"2251743220","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1657887720,"share":"https://www.laohu8.com/m/news/2251743220?lang=&edition=full","pubTime":"2022-07-15 20:22","market":"hk","language":"en","title":"Synthetic Biologics Sets 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2251743220","media":"Dow Jones","summary":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensu","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Will Feuer \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/SYN\">Synthetic Biologics Inc</a>. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n</p>\n<p>\n  The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n</p>\n<p>\n  The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Will Feuer at Will.Feuer@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  July 15, 2022 08:22 ET (12:22 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synthetic Biologics Sets 1-for-10 Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynthetic Biologics Sets 1-for-10 Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2022-07-15 20:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Will Feuer \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/SYN\">Synthetic Biologics Inc</a>. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n</p>\n<p>\n  The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n</p>\n<p>\n  The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Will Feuer at Will.Feuer@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  July 15, 2022 08:22 ET (12:22 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2251743220","content_text":"By Will Feuer \n\n\n \n\n\nSynthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American. \n\n\n  The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares. \n\n\n  The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement. \n\n\n \n\n\n  Write to Will Feuer at Will.Feuer@wsj.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  July 15, 2022 08:22 ET (12:22 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}